HCW Biologics Inc. Common Stock

HCWBNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
1.63 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
1.49
↘ 0.14 (8.83%)
POST MARKET (AS OF 06:51 PM EDT)
Post Market
AS OF 06:51 PM EDT
1.49
↘ 0.14 (8.83%)
🟢Market: OPEN
Open?$1.60
High?$1.70
Low?$1.55
Prev. Close?$1.63
Volume?778.9K
Avg. Volume?25.8M
VWAP?$1.60
Rel. Volume?0.03x
Bid / Ask
Bid?$1.33 × 100
Ask?$1.84 × 100
Spread?$0.51
Midpoint?$1.59
Valuation & Ratios
Market Cap?11.7M
Shares Out?6.7M
Float?6.1M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?2.03
EPS?-$2.53
Dividend?0.00%
Ex-Dividend?N/A

HCW Biologics Inc. Common Stock (HCWB) trades at $1.49 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, HCWB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Themes
Biotech - Drug Development›Immunology & AutoimmuneLongevity & Aging›Age-Related Therapeutics
Employees
35
Market Cap
12.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.hcwbiologics.com
Listed
2021-07-20
Address
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
Phone: 954-842-2024
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
0
Momentum?
90
Short Sent.?
25
Piotroski F-Score?6/9Mixed
Altman Z-Score?-6.58Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?62.97%Squeeze Risk
Short Interest?3.8M
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume39.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?0.09Weak
Quick Ratio?0.09Weak
Cash Ratio?0.06Low
Debt/Equity?1.14Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
73
2.03CHEAP▾
P/S?
Peers
100
S&P
72
1.77CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
Peers
100
S&P
67
2.58CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-314.4%WEAK▾
ROA?
S&P
3
-66.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$17.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist